当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:61.24亿  总市值:64.88亿
流通股本:21.04亿   总股本:22.29亿

誉衡药业(002437)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入1,426,847,101.251,007,061,544.15539,105,711.332,135,451,494.88
营业总成本1,199,249,800.08854,148,219.96463,882,978.061,906,201,168.54
其他经营收益
营业利润278,194,762.96183,528,630.5107,268,905.61404,911,016.92
利润总额279,818,227.68183,386,721.16107,129,960.84409,616,937.61
净利润251,720,096.12162,333,510.2796,667,211.33382,357,127.75
每股收益
其他综合收益-2,417,906.58-2,275,845.63-1,530,963.76-1,098,908.06
综合收益总额249,302,189.54160,057,664.6495,136,247.57381,258,219.69
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计1,528,958,290.541,405,427,295.931,349,111,397.171,318,845,985.97
非流动资产:
非流动资产合计1,849,775,824.071,856,676,041.061,792,484,158.631,815,731,813.98
资产总计3,378,734,114.613,262,103,336.993,141,595,555.83,134,577,799.95
流动负债:
流动负债合计772,935,783.06746,030,720.22709,563,333.96797,849,403.68
非流动负债:
非流动负债合计25,555,610.625,918,415.9926,395,220.2327,154,017.78
负债合计798,491,393.66771,949,136.21735,958,554.19825,003,421.46
所有者权益(或股东权益):
归属于母公司股东权益合计2,560,765,341.722,470,903,307.782,387,993,475.442,293,671,990.18
股东权益合计2,580,242,720.952,490,154,200.782,405,637,001.612,309,574,378.49
负债和股东权益合计3,378,734,114.613,262,103,336.993,141,595,555.83,134,577,799.95
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,634,159,944.081,145,170,914.47584,768,616.122,479,951,968.01
经营活动现金流出小计1,350,984,848.04963,010,256.84512,058,326.842,206,596,454.54
经营活动产生的现金流量净额283,175,096.04182,160,657.6372,710,289.28273,355,513.47
投资活动产生的现金流量:
投资活动现金流入小计755,181,063.79650,711,540.99447,631,423.671,321,760,890.23
投资活动现金流出小计952,226,272.18724,967,028.94179,282,920.311,654,113,698.98
投资活动产生的现金流量净额-197,045,208.39-74,255,487.95268,348,503.36-332,352,808.75
筹资活动产生的现金流量:
筹资活动现金流入小计105,823,162.867,319,650-90,000,000
筹资活动现金流出小计95,520,028.8774,061,887.5573,543,343.06114,050,434.38
筹资活动产生的现金流量净额10,303,133.93-6,742,237.55-73,543,343.06-24,050,434.38
汇率变动对现金及现金等价物的影响-3,860,510.37-2,859,825.3-1,436,780.01-1,887,808.59
现金及现金等价物净增加额92,572,511.2198,303,106.83266,078,669.57-84,935,538.25
期末现金及现金等价物余额488,409,663.41494,140,259.03661,907,577.33395,837,152.2
补充资料:
现金及现金等价物的净增加额-98,303,106.83--84,935,538.25
TOP↑